XERS - Xeris Biopharma Holdings, Inc.
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$9.00
DETAILS
HIGH:
$9.00
LOW:
$9.00
MEDIAN:
$9.00
CONSENSUS:
$9.00
UPSIDE:
45.40%
Profitability Ratios
| Ratio | Value |
|---|---|
| GP Margin | 81.7% |
| EBIT Margin | 0.2% |
| EBITDA Margin | 4.4% |
| Operating Margin | 8.5% |
| Pretax Margin | 0.2% |
| Cont. Ops Margin | 0.2% |
| Net Margin | 0.2% |
| Bottom Line Margin | 0.2% |
Liquidity Ratios
| Ratio | Value |
|---|---|
| Current Ratio | 2.19 |
| Quick Ratio | 1.57 |
| Solvency Ratio | 0.034 |
| Cash Ratio | 1.01 |
Valuation Ratios
| Ratio | Value |
|---|---|
| Price/Earnings |
2273.17
Peers avg: 25.2
|
| PEG Ratio | -22.52 |
| Forward PEG | -22.52 |
| Price/Book | 92.00 |
| Price/Sales | 4.32 |
| Price/FCF | 45.09 |
| Price/Op Cash Flow | 43.99 |
Debt Ratios
| Ratio | Value |
|---|---|
| Debt/Assets | 0.0985 |
| Debt/Equity | 2.7586 |
| Debt/Capital | 0.7339 |
| Long-Term Debt/Capital | 0.6973 |
| Financial Leverage | 28.02 |
Cash Flow Ratios
| Ratio | Value |
|---|---|
| Working Capital Turnover | 2.95 |
| Operating Cash Flow Ratio | 0.261 |
| Operating Cash Flow/Sales | 9.8% |
| Free Cash Flow/Operating Cash Flow | 97.6% |
Coverage Ratios
| Ratio | Value |
|---|---|
| Debt Service Coverage | 0.36 |
| Interest Coverage | 0.8560 |
| Short-Term Operating Cash Flow Coverage | 4.59 |
| Operating Cash Flow Coverage | 0.76 |
| Capital Expenditure Coverage | 41.13 |
| Dividend + Capital Expenditure Coverage | 41.13 |
Dividend Ratios
| Ratio | Value |
|---|---|
| Payout Ratio | 0.0000% |
| Dividend Yield | 0.0000% |
| Dividend Yield % | 0.0000% |
| Dividend Per Share | 0.0000 |
Per Share Ratios
| Ratio | Value |
|---|---|
| Revenue/Share | 1.82 |
| EPS | 0.003 |
| Debt/Share | 0.4167 |
| Cash/Share | 0.69 |
| Book Value/Share | 0.09 |
| Tangible BV/Share | -0.61 |
| Equity/Share | 0.09 |
| Operating Cash Flow/Share | 0.178 |
| Capital Expenditure/Share | 0.004 |
| FCF/Share | 0.174 |
Other Ratios
| Ratio | Value |
|---|---|
| Net Income/Earnings Before Tax | 1.000 |
| Earnings Before Tax/EBIT | 0.022 |
| Price/Fair Value | 92.00 |
| Debt/Market Cap | 0.0300 |
| Effective Tax Rate | 0.0% |
| Enterprise Value Multiple | 93.32 |